AIMD Insider Trading

Insider Ownership Percentage: 4.55%
Insider Buying (Last 12 Months): $48,314.03
Insider Selling (Last 12 Months): $300,000.00

Ainos Insider Trading History Chart

This chart shows the insider buying and selling history at Ainos by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ainos Share Price & Price History

Current Price: $1.18
Price Change: Price Decrease of -0.05 (-4.07%)
As of 03/27/2024 01:00 AM ET

This chart shows the closing price history over time for AIMD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ainos Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/26/2023Ting-Chuan LeeDirectorBuy61,157$0.79$48,314.0361,157View SEC Filing Icon  
4/19/2023Ainos IncMajor ShareholderSell400,000$0.75$300,000.0012,926,082View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ainos (OTCMKTS:AIMD)

0.35% of Ainos stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Ainos Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2023State Street Corp30,200$27K0.0%N/A0.151%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC44,586$84K0.0%N/A0.463%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ainos logo
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
Read More on Ainos

Today's Range

Now: $1.18
Low: $1.16
High: $1.22

50 Day Range

MA: $1.10
Low: $0.81
High: $2.05

52 Week Range

Now: $1.18
Low: $0.79
High: $6.10

Volume

72,124 shs

Average Volume

1,975,678 shs

Market Capitalization

$7.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44

Who are the company insiders with the largest holdings of Ainos?

Ainos' top insider investors include:
  1. Ainos Inc (Major Shareholder)
  2. Ting-Chuan Lee (Director)
Learn More about top insider investors at Ainos.